MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis

EMBO Journal

Volumn 19, Issue 19, 2000, Pages 5135-5147

  Ganguli, Gitali ^a   Abecassis, Joseph ^b   Wasylyk, Bohdan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CENTRE PAUL STRAUSS   (France)

Author keywords

Apoptosis; Differentiation; P53; Proliferation; Tumours

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; GENE OVEREXPRESSION; HYPERPLASIA; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

EID: 0034596987     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.19.5135     Document Type: Article

References (80)

1. MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice
2. Involvement of p53 in cell differentiation and development
3. Inhibition of UV-induced p53 mutations by sunscreens: Implications for skin cancer prevention
4. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: Immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells
5. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line
6. A common human skin tumour is caused by activating mutations in β-catenin
7. Expression of keratin K14 in the epidermis and hair follicle: Insights into complex programs of differentiation
8. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice
9. MDM-2 protein is expressed in different layers of normal human skin
10. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation
11. WAF1, a potential mediator of p53 tumor suppression
12. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
13. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
14. Amplification of MDM2 inhibits MyoD-mediated myogenesis
15. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth
16. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
17. Functions of the MDM2 oncoprotein
18. Keratins and the skin
19. Changes in keratin gene expression during terminal differentiation of the keratinocyte
20. Induction of epidermal hyperplasia, hyperkeratosis and papillomas in transgenic mice by a targeted v-Ha-ras oncogene
21. The mdm2 proto-oncogene
22. High levels of p53 protein in UV-irradiated normal human skin
23. 1 cyclin-dependent kinases
24. Mdm2 promotes the rapid degradation of p53
25. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
26. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
27. MdmX protects p53 from Mdm2-mediated degradation
28. p53 Protects against skin cancer induction by UV-B radiation
29. Frequent clones of p53-mutated keratinocytes in normal human skin
30. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
31. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
32. Mdm2: The ups and downs
33. The p53 gene family
34. Regulation of p53 stability by Mdm2
35. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
36. The scientific basis of skin cancer
37. Sequence and expression of a type II keratin, K5, in human epidermal cells
38. MDM2 expression during mouse embryogenesis and the requirement of p53
39. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
40. Regulation and function of the p53-related proteins: Same family, different rules
41. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53
42. p63 Is a p53 homologue required for limb and epidermal morphogenesis
43. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
44. The MDM2 gene amplification database
45. MDM2 - Master regulator of the p53 tumor suppressor protein
46. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
47. The 50- and 58-kDa keratin classes as molecular markers for stratified squamous epithelia: Cell culture studies
48. 35S-labeled probes for retinoid receptors
49. Amplification of a gene encoding a p53-associated protein in human sarcomas
50. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
51. Basal cell carcinomas in mice overexpressing sonic hedgehog
52. Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin
53. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation
54. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes
55. The p53-MDM2 interaction in a cancer-prone family and the identification of a novel therapeutic target
56. Mdm2: Keeping p53 under control
57. Signaling to p53: Breaking the MDM2-p53 circuit
58. Overproduction of MDM2 in vivo disrupts S phase independent of E2F1
59. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
60. The INK4a/ARF locus in murine tumorigenesis
61. The ARF/p53 pathway
62. Mechanisms of induction of skin cancer by UV radiation
63. Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction
64. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation
65. p53-Independent role of MDM2 in TGF-β1 resistance
66. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
67. p53-Dependent regulation of nucleotide excision repair in murine epidermis in vivo
68. p53-Regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
69. Ultraviolet radiation-induced p53 responses in the epidermis are differentiation-dependent
70. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation
71. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice
72. Transgenic overexpression of transforming growth factor α bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis
73. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
74. Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy
75. p53-Mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein
76. Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes
77. Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles
78. MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins
79. p63 Is essential for regenerative proliferation in limb, craniofacial and epithelial development
80. Sunburn and p53 in the onset of skin cancer